JP2001500383A - 結核診断用の化合物および方法 - Google Patents

結核診断用の化合物および方法

Info

Publication number
JP2001500383A
JP2001500383A JP10518432A JP51843298A JP2001500383A JP 2001500383 A JP2001500383 A JP 2001500383A JP 10518432 A JP10518432 A JP 10518432A JP 51843298 A JP51843298 A JP 51843298A JP 2001500383 A JP2001500383 A JP 2001500383A
Authority
JP
Japan
Prior art keywords
seq
polypeptide
antigen
dna sequence
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP10518432A
Other languages
English (en)
Japanese (ja)
Inventor
リード，スティーヴン，ジー．
スケイキー，ヤシール，エー．ダブリュ．
ディロン，ダヴィン，シー．
カンポス―ネト，アントニオ
ホウトン，レイモンド
ヴェドヴィック，トーマス，エス．
トワードジック，ダニエル，アール．
ロッジス，マイケル，ジェイ．
Original Assignee
コリックサ コーポレーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/818,111 external-priority patent/US6338852B1/en
Application filed by コリックサ コーポレーション filed Critical コリックサ コーポレーション
Publication of JP2001500383A publication Critical patent/JP2001500383A/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP10518432A 1996-10-11 1997-10-07 結核診断用の化合物および方法 Ceased JP2001500383A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US72962296A 1996-10-11 1996-10-11
US08/729,622 1996-10-11
US08/818,111 US6338852B1 (en) 1995-09-01 1997-03-13 Compounds and methods for diagnosis of tuberculosis
US08/818,111 1997-03-13
PCT/US1997/018214 WO1998016645A2 (fr) 1996-10-11 1997-10-07 Composes et procedes pour diagnostiquer la tuberculose

Publications (1)

Publication Number Publication Date
JP2001500383A true JP2001500383A (ja) 2001-01-16

Family

ID=27111919

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10518432A Ceased JP2001500383A (ja) 1996-10-11 1997-10-07 結核診断用の化合物および方法

Country Status (11)

Country Link
EP (1) EP0934415A2 (fr)
JP (1) JP2001500383A (fr)
AU (1) AU4750597A (fr)
BR (1) BR9712298A (fr)
CA (1) CA2268036A1 (fr)
CZ (1) CZ126699A3 (fr)
IL (2) IL129389A0 (fr)
NO (1) NO991693L (fr)
PL (1) PL333304A1 (fr)
TR (1) TR199901569T2 (fr)
WO (1) WO1998016645A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009503518A (ja) * 2005-07-26 2009-01-29 ユニヴァーシティ オブ メディシン アンド デンティストリ オブ ニュージャーシィ 結核状態に特有の抗体プロフィール

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6991797B2 (en) 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
US7087713B2 (en) 2000-02-25 2006-08-08 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
US6613881B1 (en) * 1997-05-20 2003-09-02 Corixa Corporation Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
US6436409B1 (en) * 1997-07-16 2002-08-20 Institut Pasteur Polynucleotide functionally coding for the LHP protein from Mycobacterium tuberculosis, its biologically active derivative fragments, as well as methods using the same
EP1484405A1 (fr) * 1997-11-10 2004-12-08 Statens Serum Institut Fragments d'acide nucléique et fragments polypeptidiques derivés de M. tuberculosis
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
US20030027774A1 (en) * 1999-03-18 2003-02-06 Ronald C. Hendrickson Tuberculosis antigens and methods of use therefor
DK1214088T3 (da) 1999-05-04 2009-08-24 Univ New Jersey Med Proteiner udtrykt af Mycobacterium tuberculosis og ikke af BCG og anvendelse heraf som diagnostiske reagenser og vacciner
AU779846B2 (en) * 1999-10-07 2005-02-17 Corixa Corporation Methods of using a mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of heterologous proteins
US7009042B1 (en) 1999-10-07 2006-03-07 Corixa Corporation Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins
US6316205B1 (en) 2000-01-28 2001-11-13 Genelabs Diagnostics Pte Ltd. Assay devices and methods of analyte detection
DK2133100T3 (da) 2000-06-20 2012-01-23 Corixa Corp MTB32A-Antigen af Mycobacterium tuberculosis med inaktiveret aktivt sted og fusionsproteiner deraf
AU2001271963A1 (en) * 2000-07-10 2002-01-21 Colorado State University Research Foundation Mid-life vaccine and methods for boosting anti-mycobacterial immunity
US7393539B2 (en) 2001-06-22 2008-07-01 Health Protection Agency Mycobacterial antigens expressed under low oxygen tension
US7393540B2 (en) 2001-07-04 2008-07-01 Health Protection Agency Mycobacterial antigens expressed during latency
DE60236659D1 (de) * 2001-07-25 2010-07-22 Tosoh Corp Auf NASBA basiertes Detektionsverfahren zur Detektion des Tuberkelbazillus
GB0125535D0 (en) * 2001-10-24 2001-12-12 Microbiological Res Authority Mycobacterial genes down-regulated during latency
US7026465B2 (en) 2002-02-15 2006-04-11 Corixa Corporation Fusion proteins of Mycobacterium tuberculosis
US8475735B2 (en) 2004-11-01 2013-07-02 Uma Mahesh Babu Disposable immunodiagnostic test system
AU2005305869B2 (en) 2004-11-16 2010-12-09 Aeras Global Tb Vaccine Foundation Multivalent vaccines comprising recombinant viral vectors
BRPI0611347A2 (pt) 2005-04-29 2010-08-31 Glaxosmithline Biolog S A composicão farmacêutica, usos de uma proteìna de fusão mtb72f ou um fragmento imunogênico da mesma, e, de um ácido nucléico
CN100999550B (zh) 2006-01-10 2010-10-06 中国人民解放军第三○九医院 结核分枝杆菌融合蛋白及其应用
GB0618127D0 (en) * 2006-09-14 2006-10-25 Isis Innovation Biomarker
EP2368568A1 (fr) 2006-11-01 2011-09-28 Immport Therapeutics, INC. Compositions et procédés pour antigènes immunodominants
PL2528621T3 (pl) 2010-01-27 2017-07-31 Glaxosmithkline Biologicals S.A. Zmodyfikowane antygeny gruźlicy
CN115746092B (zh) * 2022-08-12 2024-08-13 齐鲁工业大学 具有抗氧化、抗衰老活性的钝顶螺旋藻藻蓝蛋白活性肽及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244539A1 (en) * 1973-07-13 1975-04-18 Mitsui Pharmaceuticals Tuberculin active proteins and peptides prepn - from tubercle bacillus
FR2265402A1 (en) * 1974-03-29 1975-10-24 Mitsui Pharmaceuticals Tuberculin active proteins and peptides prepn - from tubercle bacillus
EP0419355B1 (fr) * 1989-09-19 2000-02-09 N.V. Innogenetics S.A. Polypeptides et peptides recombinantes, acides nucléiques lesencodantes, et l'utilisation de celles-ci pour le diagnostique de la tuberculose
FR2677365B1 (fr) * 1991-06-07 1995-08-04 Pasteur Institut Proteines de mycobacterium et applications.
US5330754A (en) * 1992-06-29 1994-07-19 Archana Kapoor Membrane-associated immunogens of mycobacteria
DK79893D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut New vaccine
DK79793D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut Diagnostic test
US5714593A (en) * 1995-02-01 1998-02-03 Institut Pasteur DNA from mycobacterium tuberculosis which codes for a 45/47 kilodalton protein
ATE513915T1 (de) * 1995-09-01 2011-07-15 Corixa Corp Verbindungen und verfahren zur immuntherapie und diagnose von tuberkulose
DK2154248T3 (da) * 1995-09-01 2012-01-30 Corixa Corp Forbindelser og fremgangsmåder til diagnose af tuberkulose

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009503518A (ja) * 2005-07-26 2009-01-29 ユニヴァーシティ オブ メディシン アンド デンティストリ オブ ニュージャーシィ 結核状態に特有の抗体プロフィール

Also Published As

Publication number Publication date
NO991693L (no) 1999-06-09
IL121936A0 (en) 1998-03-10
BR9712298A (pt) 2000-10-24
PL333304A1 (en) 1999-11-22
WO1998016645A3 (fr) 1998-08-06
NO991693D0 (no) 1999-04-09
CA2268036A1 (fr) 1998-04-23
EP0934415A2 (fr) 1999-08-11
CZ126699A3 (cs) 1999-09-15
WO1998016645A2 (fr) 1998-04-23
TR199901569T2 (xx) 2000-12-21
IL129389A0 (en) 2000-02-17
AU4750597A (en) 1998-05-11

Similar Documents

Publication Publication Date Title
US7122196B2 (en) Compounds and methods for diagnosis of tuberculosis
JP2001500383A (ja) 結核診断用の化合物および方法
EP0850305B1 (fr) Composes et methodes de diagnostic de la tuberculose
US7989605B2 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
US7927609B2 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
EP0851927B1 (fr) Composes d'immunotherapie et de diagnostic de la tuberculose
CA2290754A1 (fr) Composes permettant de diagnostiquer la tuberculose et leurs procedes d'utilisation
WO1997009428A9 (fr) Composes et methodes d'immunotherapie et de diagnostic de la tuberculose
CA2331845A1 (fr) Composes et procedes servant a diagnostiquer et a traiter l'infection par ehrlichia
EP0834567A2 (fr) Composés et méthodes pour le diagnostique et le traitement d'infections à Babesia microti
EP1712629A2 (fr) Composés et procédés pour le diagnostic de la tuberculose
KR20000049100A (ko) 결핵을 진단하는 화합물 및 방법

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20041007

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070130

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20070620

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070731